922D947A5D899BA2F02F9B95B83A152100C07D6DA3006BB7AF1328F21C494FBD43A9D44004A80DCF1EB4598BFAA074AE

Failed in phase II clinical trial. Was tested under the name CGX-1007 by Cognetix Inc. to treat convulsion and epilepsy.

Source:http://purl.uniprot.org/SHA-384/922D947A5D899BA2F02F9B95B83A152100C07D6DA3006BB7AF1328F21C494FBD43A9D44004A80DCF1EB4598BFAA074AE

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
rdfs:comment
Failed in phase II clinical trial. Was tested under the name CGX-1007 by Cognetix Inc. to treat convulsion and epilepsy.